Weekly Roundup -
January 7, 2026
Smart. Strategic. Essential.
Unmatched Healthcare Insights from 量子资源网,
Leavitt Partners & Wakely.
Featured:
Webinar Replay – The ACCESS Model: Essentials for Applicants
ACCESS WEBINARTrending: In Focus
New Year, New Look for 量子资源网 Weekly Roundup
Welcome to the new and improved 2026 量子资源网 Weekly Roundup鈥攜our single source for the insights that matter.
This year, we鈥檙e bringing together the full strength of 量子资源网 (量子资源网), including 量子资源网, Wakely, Investor Services, and the Leavitt Partners Digital Health Intelligence Briefing into one modernized, streamlined newsletter designed to keep you ahead of what鈥檚 coming next in health and human services.
We鈥檙e excited to deliver a clearer, more connected view of the issues shaping 2026 and to support your work with relevant and actionable insights throughout the year.
Stay Connected and Informed
- Sign up for the Weekly Roundup and ensure you are signed up to receive notifications of webinars, reports, and news on your topics of interest.
- Follow 量子资源网 , as well as our new .
- Sign up to .
CMS Announces Rural Health Transformation Program Awardees
On December听29,听2025, the Centers for Medicare & Medicaid Services (CMS)听听the state awards for the Rural Health Transformation Program (RHTP), a听$50 billion听federal initiative intended to stabilize rural health systems and support transformation.听CMS听stated听that听$10 billion听will be听available each year from 2026听to听2030, and that first-year (2026)听state听awards average $200 million, with听totals听ranging from $147 million to $281 million.听
This announcement marks a pivot from planning to execution. In the coming months, states will move rapidly to听finalize听governance structures, confirm partners, and translate proposed initiatives into operational workplans and measurable outcomes.听
Although CMS announced the overall awards for the first budget year,听some states have signaled they听continue to听work听with CMS听on听initiative-specific budgets and planning.听In听this article,听量子资源网 (量子资源网)听reviews听key themes and听early听trends听based on the application听initiatives听and what is known听about the budgets.听
What the Awards Suggest 量子资源网 State Priorities听
Although听each state鈥檚 awarded approach reflects local realities, early patterns across awardees鈥 project abstracts suggest several recurring priorities that may shape implementation activity in 2026.听
1) Building the Data, Analytics, and Interoperability Backbone
A number of awardees prioritized shared infrastructure for interoperability, analytics, performance monitoring, and operational backbone capabilities.听Examples include:听
- Arizona听described plans to secure vendors to build secure data pipelines, dashboards, and fiscal tracking tools that meet federal audit standards to support rural transformation.听
- New Mexico听proposed听a Rural Health Data Hub to build a statewide health analytics platform that integrates siloed data sources and expands access to听timely, actionable information for providers.听
- Alaska described听technology-focused investments to strengthen cybersecurity,听facilitate听data sharing and interoperability, and expand digital tools (including consumer-facing tools and remote modalities).听
2) Strengthening Maternal Health and Perinatal Care
Many awardees emphasized stabilizing rural maternity access and strengthening perinatal supports through strategies,听such as:听
- Alabama proposed听a Maternal and Fetal Health initiative featuring digital obstetric regionalization and telerobotic ultrasound to extend specialty access in rural settings.听
- Kentucky prioritized听maternal and infant health by addressing maternity care deserts, including telehealth-enabled community-based maternal/infant support teams and expanded perinatal care access.听
- Ohio听proposed legislative reforms to allow low-risk birthing centers in rural hospitals as part of its broader strategy to address maternity care deserts and improve rural access to care.听
Why听it matters: Rural maternity deserts and workforce constraints听remain听critical drivers of avoidable complications and adverse outcomes. Approaches piloted in rural settings may inform broader statewide maternity听care听strategies.听
3) Modernizing Emergency Medical Services and Mobile Care
Several awardees included investments听intended to strengthen emergency response and build more reliable rural stabilization capacity.听
- Alabama proposed听statewide听emergency medical services (EMS)听initiatives, including听trauma and听stroke routing/diversion improvements and an EMS听treat-in-place model for low-acuity patients.听
- Wyoming emphasized听access to 鈥渢he basics,鈥 including听improvements in the听ability of听hospitals听to听effectively treat emergencies and ambulance response, alongside incentives for small ambulance services to听consolidate听around more sustainable regional funding bases.听
Why听it听matters: EMS听and mobile听response听models can function as connective tissue in rural systems with听limited听traditional access points.听
Why听it听matters: Data-sharing infrastructure can enable multi-provider coordination, performance tracking, and the operational foundations needed for sustainable transformation.听
4) Integrating Behavioral Health and Community-Based Supports
Awards also reflected ongoing efforts to expand behavioral health access and improve integration with physical health and community supports.听For example:听
- Alabama听proposed听to improve behavioral health access by converting Community Mental Health Centers into Certified Community Behavioral Health Clinics (CCBHCs).听
- Arizona听proposed听to invest in behavioral health and substance use disorder treatment expansion as part of its Priority Health Initiatives portfolio.听
- Wyoming included听statewide telepsychiatry and crisis intervention services as part of its health outcomes priorities.听
Why听it听matters: Behavioral health capacity constraints are听frequently听more acute in rural areas, and integration strategies often require both听reliable听workforce and technology听supports.听
What to Watch Next听
With awards announced, attention will quickly听turn听to implementation. Stakeholders should听have processes听to听track听the following:听
- State听governance听decisions听(including lead agencies, subawards, and regional structures)听and funding听opportunities听
- State听partner selection processes听(through requests for proposals, vendor onboarding, or other contracting pathways)听
- Performance measurement and reporting expectations (including metrics and evaluation approaches)听
- Sequencing of the initiatives听and where听near-term operational activity is most likely to concentrate听
CMS also signaled near-term oversight and engagement mechanisms,听state-assigned CMS project officers, kickoff meetings, ongoing听technical听assistance, and regular progress updates, along听with听a planned annual CMS Rural Health Summit.听
Tracking State RHTP Implementation听
The听量子资源网 Information Services (量子资源网IS)听team听developed听a听resource听to听capture听available information about state RHTP activities, applications, and initiatives and provide a road听map for听identifying听state-specific proposals, requested funding, governance structures, and other key aspects of state RHTP initiatives.听
Following CMS鈥檚 award announcement, 量子资源网IS is updating听this听Rural Health Transformation Program (RHTP)听Tracker听to incorporate award-specific details as they become publicly available. The听resource includes information about听FY26 awards by state听and initiatives, links to CMS materials and state-posted implementation documentation, and a听consolidated听view of emerging themes and trends as implementation accelerates in 2026.听
Looking Ahead听
The award announcement is the beginning of implementation. As states operationalize initiatives in early 2026, organizations that align early to awarded priorities and implementation timelines will be best positioned to support rural-first efforts that deliver measurable and lasting听results.听
Executive Branch Actions Target Drug Affordability in New Pricing Models
The federal drug pricing landscape continues to undergo significant transformation as executive branch agencies advance an ambitious suite of regulatory and听model听testing initiatives听intended to听lower听the听costs听associated with听the听Medicare and Medicaid听programs.听In response to听ongoing concerns about听rising听out-of-pocket听costs,听increasing pressure to align US prices with those paid internationally, and the continued听implementation of the Inflation Reduction Act (IRA),听federal agencies听are听reshaping听how prescription drugs are priced, reimbursed, and negotiated in federally financed听programs.听
The current听policy environment reflects a growing emphasis on听benchmarking听drug prices to those in peer听nations, referred to as 鈥渕ost favored nation鈥 (MFN) benchmarks,听and accelerating actions that require or encourage manufacturers to offer lower net prices.听量子资源网 (量子资源网),听is tracking these developments in the public payer space, replicating听Centers for Medicare & Medicaid Services (CMS)听payment methodologies, and modeling alternative policies to assist life science companies, payers, and other stakeholders.听
In this article, we review听the听administration鈥檚 recent听efforts听to reduce Medicare and Medicaid spending on drugs and biologics, including听confidential听manufacturer听negotiations and three new听models听that听together听could reshape pricing dynamics across federal programs.听
Executive Branch Negotiations Seek to Drive Access to听MFN听Discounts听
In听2025, the听administration听issued听an听听directing federal agencies to pursue strategies to听establish听MFN pricing,听linking US prices for certain drugs to the lowest (or听second lowest) adjusted net prices among a targeted set of peer countries. Following the order, federal officials sent听听to 17 major pharmaceutical and biotechnology manufacturers, urging them to negotiate agreements that would voluntarily align prices with听MFN-based听benchmarks.听
To date, 14 manufacturers have signed听, though full details听remain听confidential. These agreements are听understood听to听accomplish听the following:听
- Provide听state听Medicaid听programs with听access to听MFNbased听discounts听
- Require that new drugs be launched in the United听States听at听MFNaligned听prices听
- Offer certain drugs at discounted听directtoconsumer听prices through a forthcoming 鈥淭rumpRx鈥 program, expected to launch later this year听
Reports suggest that manufacturers听entering听these听MFN-related听arrangements may receive exemptions from several federal actions, including the听Center for Medicare and Medicaid Innovation (Innovation Center)听demonstration models described below and certain听tariff-related听policies.听
MFNLinked听Models听Designed听to Lower Drug Costs Across Medicare and Medicaid听
Along听with听the negotiation efforts,听the听CMS听Innovation Center听has proposed three听models that would听test听MFNbased听pricing through structured rebate mechanisms. Each model targets different segments of the market while testing how international benchmarks could be integrated into federal drug payment policy.听
New Models Test Alternatives to Inflation Rebates听
Announced听in听December 2025,听the听听and听the听听are designed to test alternative approaches to the听Inflation Reduction Act鈥檚 (IRA)听听policies.听CMS听plans听to test the models鈥櫶齪otential for听market听driven听price reductions if manufacturers choose to lower list prices instead of paying听MFN-based听rebates.听
Key features of the GLOBE听Model听are as follows:听
- Applies听to听25 percent of听Medicare听fee-for-service听(FFS)听beneficiaries听using certain听Part B drugs听
- Beginning in October 2026,听becomes听mandatory听for select drugs and targets听highspending,听physicianadministered听Part B categories, excluding products already subject to IRA听negotiations, generics, biosimilars, and certain听lowspend听products听
- No changes to听physician and hospital听reimbursement,听although beneficiaries听expected to听see reduced cost sharing听
The听GUARD听Model听will听similarly听test whether applying MFN-based听rebates to听Medicare听Part D drugs听will lower Medicare costs.听Key aspects of this model include:听
- Fiveyear听model听that would start听January 1, 2027听
- Target听therapeutic categories with more than $69 million in annual Part D spending听
- No impact on听plan bids and beneficiary cost sharing听
These models rely on听pricing data from听19 countries. Manufacturers that voluntarily听submit听net price information would trigger quarterly benchmark updates; otherwise, CMS will use a fixed听list听price听based听benchmark for the entire听pilot听period.听
CMS is seeking听听on whether听additional听categories, for example听cell and gene therapies,听should be excluded听from GLOBE.听GUARD is also open for听听through February 23, 2026.听
GENErating听cost Reductions听fOr听US听Medicaid (GENEROUS) Model听
The听, expected to begin in 2026, creates a voluntary pathway for听state Medicaid programs and manufacturers to enter supplemental rebate听agreements tied to听MFNaligned听prices. MFN听pricing听under this model is based on the听second lowest听net price in G7 countries plus Denmark and Switzerland. GENEROUS is also expected to align with听pricing commitments negotiated听through the听administration鈥檚 manufacturer agreements.听
Key Considerations and Potential Impacts听
The听combined effect of federal negotiations and听Innovation Center听models could be听substantial, though outcomes will depend on听manufacturer听participation, benchmark stability, and operational feasibility. Key considerations include:听
- State听Medicaid savings, especially听the extent to which听MFN鈥linked rebates exceed existing supplemental rebates听
- Reduced Medicare beneficiary cost sharing for Part B included in GLOBE听
- Shifts in manufacturer pricing strategies, including potential changes to US launch prices听
- Interactions with the IRA, particularly Part D redesign and Part B inflation penalties听
Connect with Us听
量子资源网 experts听continue听to track听the federal drug pricing landscape closely as comments, operational details, and implementation timelines evolve across these initiatives.听Our team replicates CMS payment methodologies and models alternative policies听using the most current Medicare听FFS听and Medicare Advantage (100%) claims data.听
For more information听and听questions about the policies described听in this article, please contact听Kevin Kirby听and听Amy Bassano.听
Federal Policy News
Fueled By Weekly Health Intelligence
CMS Announces New ACO Model to Replace ACO REACH
The Centers for Medicare & Medicaid Services (CMS)听听on December 18, 2025, the Long-term Enhanced ACO Design (LEAD) Model, which will replace the Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model. LEAD is a 10-year voluntary Medicare initiative model that runs from January 1, 2027, through December 31, 2036. The request for applications will be released in March 2026.
The LEAD model is intended to include more small, rural, and independent providers and community health centers, enhance evidence-based prevention and care coordination, and allow patients to be more involved in their care. The model will integrate high-needs patients, including patients with complex needs and dually eligible beneficiaries, and provide flexible, capitated population-based payments to support team-based care and downstream value-based care arrangements. During the initial planning phase from March 2026 through December 2027, CMS will also identify two states to partner with to develop a framework for ACO-Medicaid partnership arrangements. ACOs in these states will have the opportunity to enter partnership arrangements with Medicaid organizations.
CDC Finalizes Changes to U.S. Childhood Vaccine Schedule
On January 5, Acting CDC Director Jim O鈥橬eill signed a adopting a revised childhood and adolescent immunization schedule for the U.S. The new schedule recommends fewer vaccines but continues to follow a three-category approach: Immunizations Recommended for All Children; Immunizations Recommended for Certain High-Risk Groups or Populations, and Immunizations Based on Shared Clinical Decision-Making.
As had been reported in the weeks leading up to the release of the memo, HHS seeks to base the U.S. schedule largely off of Denmark鈥檚, and recommends all children receive immunizations for measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B (Hib), pneumococcal disease, and human papillomavirus (HPV). The revised schedule also includes the varicella vaccine in Category 1, which is not on the Danish schedule. The revised schedule recommends one dose of the HPV vaccine rather than two.
Vaccines for RSV, hepatitis A, hepatitis B, and meningococcal disease will now be in Category 2 and only recommended for those at high risk. Vaccines for dengue will remain in this category and are recommended for children with laboratory-confirmed previous dengue virus infection and who are living in dengue-endemic areas.
Vaccines for rotavirus, COVID-19, influenza, meningococcal disease, hepatitis A, and hepatitis B will no longer be universally recommended, but shifted to Category 3 in which they are recommended based on 鈥渟hared clinical decision-making.鈥
The decision memorandum notes that as all immunizations remain on the schedule they will continue to be covered without cost-sharing by private insurance, Medicaid, CHIP, and the Vaccines for Children program. CDC specifically states in the regarding the changes that 鈥淎ll immunizations recommended by the CDC as of December 31, 2025, will continue to be fully covered by Affordable Care Act insurance plans and federal insurance programs, including Medicaid, the Children鈥檚 Health Insurance Program, and the Vaccines for Children program.鈥
Telemedicine Flexibilities for Controlled Medications Extended
On December 31, HHS and the Drug Enforcement Administration (DEA) jointly issued the of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications through December 31, 2026. The agencies had previously extended these COVID-19 pandemic-era flexibilities through the end of 2025. The extension will allow providers to continue to prescribe certain controlled medications via telemedicine, even if the provider has not evaluated the patient in person. In the rule, HHS and DEA state that the year-long extension will provide time for DEA to promulgate a final set of regulations, 鈥渢o ensure a smooth transition for patients and providers that have come to rely on the availability of telemedicine to prescribe controlled substances to patients for whom they have never had an in-person medical evaluation, and allow sufficient time for providers to come into compliance with any new DEA registration, recordkeeping, or security requirements eventually adopted in a final set of regulations.鈥
CMS Updates Medicaid and CHIP Quality Measures for 2026鈥2027
On December 30, CMS a State Health Official (SHO) letter outlining updates to the 2026 and 2027 Child and Adult Core Set of Quality Measures for Medicaid and CHIP, with a focus on immunizations. As part of the 2026 revisions, CMS is removing four pediatric and prenatal immunization measures from the Child and Adult Core Sets:
- Childhood Immunization Status (CIS鈥慍H);
- Immunizations for Adolescents (IMA鈥慍H);
- Prenatal Immunization Status: Under Age 21 (PRS鈥慍H); and
- Prenatal Immunization Status: Age 21 and Older (PRS鈥慉D).
According to the letter, states may continue to voluntarily report results for these four Utilization Measures, enabling CMS to 鈥渕aintain a longitudinal dataset while evaluating alternative immunization metrics.鈥 Additionally, the Childhood Immunization Status (CIS鈥慍H) and Immunizations for Adolescents (IMA鈥慍H) measures will no longer be subject to mandatory stratification in 2026.
In the letter, CMS also notes it plans to develop new vaccine-related measures that assess whether families are informed about 鈥渧accine choices, vaccine safety and side effects, and alternative vaccine schedules.鈥 Stakeholder engagement with states, measure stewards, immunization registry managers, providers, and EHR vendors will help shape these measures, with consideration for religious exemptions. These changes follow a series of vaccine policy shifts initiated under the Trump Administration, including the HHS recommended vaccine schedule changes announced today and recent changes to recommendations for hepatitis B vaccination in newborns, removing universal vaccination recommendations and instead advising vaccination only for infants born to mothers with hepatitis B or unknown infection status.
Ready to talk about your organization's challenges?
Schedule a ConsultationState Policy News
Georgia
Georgia Proposes Restructuring 1915c Waiting List for Individuals with IDD. GPB/Georgia Recorder听听on January 2, 2026, that Georgia鈥檚 Department of Behavioral Health and Developmental Disabilities is evaluating proposed changes to the state鈥檚 1915(c) Home and Community-Based Services (HCBS) waiver waiting list for individuals with intellectual and developmental disabilities. The recommendations would replace the current single planning list with a three-tiered system based on urgency of need, enhance assessment and data collection, and potentially introduce an additional waiver option for individuals who do not qualify under existing programs such as the New Options Waiver and Comprehensive Supports Waiver Program. The proposals have not yet been finalized or assigned an implementation timeline and are being considered amid broader Medicaid funding constraints.
Illinois
Cityblock, Centene Launch Value-Based Medicaid Partnership in IL.听Cityblock听Health鈥鈥痮n January 7, 2026, that it has partnered with Centene鈥檚 Meridian Health Plan of Illinois to serve approximately 10,000 Medicaid members across 17 counties in the Springfield and St. Louis Metro East regions of Illinois.听Cityblock听will deliver 24/7 wrap-around, value-based care, including primary, behavioral, social, pharmacy, and care management services, integrated with Meridian鈥檚 provider network. The collaboration expands听颁颈迟测产濒辞肠办鈥檚听Illinois footprint and听represents听the fourth regional partnership between听Cityblock听and Centene, following New York, Ohio, and Florida. The partnership aims to improve care coordination, access, and outcomes for high-need Medicaid听
Nevada
Nevada Implements Medicaid Billing Platform for School Health Services. The Nevada Health Authority announced on December 31, 2025, that it has launched a statewide initiative to help schools access Medicaid reimbursement for eligible student health services by implementing a shared electronic health record and Medicaid billing platform through an external vendor. The program is intended to reduce administrative and billing barriers that have historically limited schools鈥 ability to claim Medicaid funds, while expanding support for student mental health services, primary and preventive care, and special education. Funded by a federal grant to Nevada Medicaid, the initiative aims to strengthen the sustainability and reach of school-based health services across the state.
Indiana
Indiana Medicaid Forecast Projects Nearly $466 Million in Savings Over FY 2026-27 Biennium. The Indiana Family and Social Services Administration (FSSA)听听on December 18, 2025, that its December 2025 Medicaid forecast shows the state is on track to save $314.1 million in fiscal 2026 and $151.8 million in fiscal 2027, totaling $465.9 million over the biennium. The savings are largely due to declining Medicaid enrollment in the Healthy Indiana Plan (HIP) and Hoosier Healthwise (HHW) after changes to eligibility redetermination procedures, which included a ban on Medicaid advertising. State officials are still cautioning of challenges ahead, including economic uncertainty, policy shifts, and high-cost service areas, which could affect Medicaid鈥檚 long-term sustainability.
Minnesota
MN Releases Strategy, Supports RFPs for Individuals with Disabilities, SMI. The Minnesota鈥檚 Department of Human Services has鈥鈥痑 request for proposals (RFP) on January 5, 2026, seeking innovative solutions to improve outcomes for people with disabilities. The solicitation prioritizes projects serving individuals eligible for or receiving Section 1915(c) home and community-based services and supports initiatives focused on integrated housing, competitive employment, accessible transportation, and community-centered, culturally responsive services. Letters of Interest are due January 27, 2026.鈥 , the Department of Human Services鈥 Behavioral Health Administration issued a request for proposals on January 2, 2026, for a one-time $400,000 grant to a women-led organization to provide mental health services and supports to New Americans that are adults living with serious mental illness and residing in Minneapolis. Full proposals for this opportunity are due January 26, 2026.听
Private Market News
Fueled By
FDA Gets Mixed Feedback on Performance Monitoring for AI
Medtech industry groups said the FDA should use existing regulatory and quality tools to monitor performance, while medical groups said device manufacturers should be responsible for monitoring AI. .
Changes to Healthcare Price Transparency Rules Planned
On December 19, CMS, in partnership with the Department of Labor and the Department of the Treasury, released a building on healthcare price transparency rules established during President Trump鈥檚 first term. The proposed rule specifically seeks to address three key challenges identified by the administration: 鈥渋naccessibility due to the large size of the machine-readable files, data ambiguity due to lack of contextual information alongside the raw data, and areas of misalignment with the Hospital Price Transparency rule that make comparing data across disclosures challenging.鈥 The provisions of the rule primarily apply to non-grandfathered group health plans and health insurance issuers offering non-grandfathered group and individual health insurance coverage.
The rule proposes several requirements intended to address the burden of reporting on providers and plans issuers, and simplify the organization and accessibility of the data for consumers and researchers. These include reduced reporting frequency, expanded out-of-network pricing disclosures, and requirements for new change-log and utilization files to improve data usability. CMS also proposes to require issuers to provide personalized cost-sharing estimates via online tool, paper, and (starting for policy years on/after January 1, 2027) by phone, in line with price comparison guidance mandate requirements of the No Suprises Act.
The proposed rule is open for public comment until February 21, 2026.
Our Insights
Fueled By Experts Across Our 量子资源网 Companies
量子资源网
Webinar: The ACCESS Model: Essentials for Applicants
CMS鈥檚 new ACCESS model represents one of the most ambitious federal efforts to modernize chronic care through technology-supported services. This national, voluntary, decade-long model creates a new payment pathway for digital health tools, continuous monitoring, behavioral support, and other tech-enabled interventions that complement traditional care. With beneficiaries able to enroll directly and clinicians eligible for co-management payments, ACCESS introduces a fundamentally different approach to chronic condition management across Medicare.
In this webinar, 量子资源网 and Leavitt Partners experts will break down what is known today, what to expect in the forthcoming Request for Applications, and what organizations can do to prepare. We will walk through the model鈥檚 four clinical tracks, outcomes-aligned payments, beneficiary engagement expectations, the TEMPO pilot鈥檚 implications for digital device manufacturers, and how it relates to the CMS Health Tech Ecosystem initiative.
Webinar: Meeting the Healthcare Needs of Unhoused People Part 1: Service and Care Responses
Join听量子资源网 experts and our featured speakers听for the first of two webinars exploring how current events are impacting people experiencing homelessness and their access to care. This webinar will highlight the model of care for healthcare for the homeless clinics and medical respite care providers and how these services interact with broader systems of care. Additionally, we will explore how the current environment is impacting delivery and financing of care for some of our most vulnerable neighbors.听
Webinar: Meeting the Healthcare Needs of Unhoused People Part 2: State Policy Responses
Recent federal policy changes, such as the 2025 Budget Reconciliation Act (OBBBA), bring significant challenges to听retaining听the Medicaid coverage gains and added 1115听demonstration听services that have been so successful in the last decade. States will be under tremendous pressure to meet new requirements鈥攂ut they also have options to reduce the negative impact on vulnerable populations and the healthcare providers that serve them. Join听量子资源网 and our featured experts听for this听webinar听to discuss state-level policy options, share resources, and consider how to move forward in the current environment.听
Wakely
Enrollment Dynamics and Health Care Utilization in the ACA Individual Market
Wakely was retained by America鈥檚 Health Insurance Plans (AHIP) to evaluate the potential reasons for reported changes in the percent of non-claimants in some individual health insurance markets over the reported period. This report explains what that statistic measures and how best to interpret it.
To gain additional understanding of potential drivers of the elevated non-claimant ratios in the individual market, Wakely reviewed its ACA database to highlight key dynamics contributing to the higher non-claimant ratios. The paper discusses the data used to measure non-claimant ratios and its limitations, changes in enrollment patterns in 2022 and 2023 in the individual market, as well as how changes in 2025 relative to 2024 may result in lower non-claimant ratios.
ESRD: The Forgotten Group
End-Stage Renal Disease (ESRD) represents one of Medicare鈥檚 most medically complex and financially costly populations yet historically has been underserved in both Medicare and Medicare Advantage (MA). Despite representing less than 1% of total beneficiaries, ESRD accounts for a disproportionately large share of Medicare expenditures. Traditional MA plans often lack the specialized networks, care coordination, and benefit designs required to address ESRD patients鈥 intensive needs. While ESRD Chronic Condition Special Needs Plans (C-SNPs) have begun to fill this gap, their adoption remains extremely limited nationwide.
In 2026, CMS is expanding the C-SNP condition category from ESRD to CKD (chronic kidney disease), allowing plans to serve beneficiaries across the full kidney disease continuum鈥攆rom earlier-stage CKD to dialysis-dependent ESRD. This policy shift enables MA plans to intervene sooner, coordinate care more effectively, and help patients avoid or delay kidney failure, ultimately improving quality of life and reducing long-term costs. Integrating CKD and ESRD into a single SNP also aligns with CMS鈥檚 value-based care strategy and addresses significant equity gaps. This paper outlines the challenges ESRD patients face, the limitations of current MA benefits, the unique requirements of ESRD C-SNPs, and the potential impact of the upcoming CKD-ESRD SNP model.
Summary of CMS鈥檚 CY2027 Proposed Rule
On November 25, 2025, the Centers for Medicare and Medicaid Services (CMS) released the 鈥淐Y2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program鈥. The deadline to听submit听comments is January 26, 2026. This summary is primarily focused on the financial and actuarial aspects of the Proposed Rule.听
RFP Calendar
RFP Calendar
| Date | State/Program | Event | Beneficiaries |
|---|---|---|---|
| Date: DELAYED | State/Program: Texas STAR & CHIP | Event: Implementation | Beneficiaries: 4,600,000 |
| Date: December 2025 - February 2026 | State/Program: Texas STAR Kids | Event: Awards | Beneficiaries: 150,000 |
| Date: January 1, 2026 | State/Program: Wisconsin LTC GSR 2,7 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: January 1, 2026 | State/Program: Michigan HIDE SNP | Event: Implementation | Beneficiaries: 35,000 |
| Date: January 1, 2026 | State/Program: Nevada D-SNP | Event: Implementation | Beneficiaries: 88,000 |
| Date: January 1, 2026 | State/Program: Ohio Duals | Event: Implementation | Beneficiaries: 250,000 |
| Date: January 1, 2026 | State/Program: Illinois D-SNP | Event: Implementation | Beneficiaries: 79,000 |
| Date: January 1, 2026 | State/Program: Nevada | Event: Implementation | Beneficiaries: 674,000 |
| Date: January 1, 2026 | State/Program: Massachusetts One Care, Senior Care Options | Event: Implementation | Beneficiaries: 120,000 |
| Date: January 6, 2026 | State/Program: Nevada Children's Specialty | Event: Proposals Due | Beneficiaries: NA |
| Date: January 16, 2026 | State/Program: Wisconsin LTC GSR 3 | Event: Proposals Due | Beneficiaries: 56,000 (all GSR) |
| Date: January 21, 2026 | State/Program: Illinois Tailored Care Management Program | Event: Proposals Due | Beneficiaries: 22,400 |
| Date: February 2026 | State/Program: Illinois | Event: Awards | Beneficiaries: 2,400,000 |
| Date: February 19, 2026 | State/Program: Nevada Children's Specialty | Event: Awards | Beneficiaries: NA |
| Date: June 24, 2026 | State/Program: Wisconsin LTC GSR 3 | Event: Awards | Beneficiaries: 56,000 (all GSR) |
| Date: December 2026 - February 2027 | State/Program: Texas STAR Kids | Event: Implementation | Beneficiaries: 150,000 |
| Date: January 1, 2027 | State/Program: Illinois | Event: Implementation | Beneficiaries: 2,400,000 |
| Date: January 1, 2027 | State/Program: Nevada Children's Specialty | Event: Implementation | Beneficiaries: NA |
| Date: January 1, 2027 | State/Program: Wisconsin LTC GSR 3 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: January 1, 2027 | State/Program: Illinois Tailored Care Management Program | Event: Implementation | Beneficiaries: 22,400 |
| Date: January 1, 2028 | State/Program: Wisconsin LTC GSR 4,6 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: Fall 2027 | State/Program: Oregon | Event: RFP Release | Beneficiaries: 1,200,000 |
| Date: 2028 | State/Program: North Carolina | Event: RFP Release | Beneficiaries: 2,200,000 |